Last updated: June 2, 2026. Reviewed by the Vital Signs Today editorial team. Sourced from primary research and FDA regulatory records.

Peptides are short chains of amino acids, usually 2 to 50 of them, that act as signaling molecules in the body. Some peptides are FDA-approved medicines with strong clinical evidence, such as the GLP-1 drugs used for diabetes and weight loss. Others, sold online or through wellness clinics, have far thinner data and unsettled legal status. This guide separates the two.

What are peptides, in plain English?

A peptide is a short chain of amino acids linked together. Amino acids are the same building blocks that make up proteins, so the simplest way to think about a peptide is a very small protein. The body makes thousands of its own peptides to carry messages between cells, regulate blood sugar, trigger tissue repair, and control hormones like insulin and growth hormone.

Because peptides are signals rather than bulk structural material, a tiny amount can produce a large effect. That is exactly why they are interesting as drugs, and also why getting the dose and the molecule wrong can be risky.

What is the difference between a peptide and a protein?

The difference between a peptide and a protein is mostly size. Chains of roughly 2 to 50 amino acids are called peptides; longer chains that fold into complex three-dimensional shapes are called proteins. Insulin, at 51 amino acids, sits right on the border and is often described as a small protein.

This size difference matters for how you take them. Most peptides are destroyed by stomach acid and digestive enzymes, which is why drugs like semaglutide are usually injected. The newer oral versions survive digestion only because of special chemical tricks or absorption enhancers.

How do peptides work in the body?

Peptides work by binding to receptors on the surface of cells, like a key fitting a lock, and switching a specific biological process on or off. A GLP-1 peptide, for example, binds to GLP-1 receptors in the pancreas, gut, and brain to increase insulin, slow stomach emptying, and reduce appetite.

This receptor specificity is the appeal. A well-designed peptide can target one pathway and leave others mostly alone, which can mean fewer side effects than older small-molecule drugs. The catch is that the same precision makes peptides sensitive to small changes in structure, purity, and dose, which is where unregulated products run into trouble.

What are the main types of peptides people ask about?

The peptides getting the most attention in 2026 fall into a few groups, and the quality of evidence behind them varies enormously. The table below is the fastest way to see where each one stands.

Peptide group Common examples Claimed use Evidence and legal status
GLP-1 receptor agonists Semaglutide, tirzepatide Type 2 diabetes, weight loss Strong. FDA-approved, large trials
Healing peptides BPC-157, TB-500 Tendon, gut, soft-tissue repair Weak in humans. Not FDA-approved
Growth hormone secretagogues Ipamorelin, CJC-1295, sermorelin Muscle, recovery, anti-aging Limited. Mostly off-label or research use
Collagen peptides Hydrolyzed collagen Skin, hair, joints Mixed. Funding bias is a real problem

GLP-1 receptor agonists: the peptides with real evidence

GLP-1 receptor agonists are the most studied and most clearly effective peptides on this list. In the head-to-head SURMOUNT-5 trial published in the New England Journal of Medicine in 2025, adults on tirzepatide lost an average of 20.2% of body weight over 72 weeks, compared with 13.7% on semaglutide. These are prescription medicines with decades of combined safety data behind them.

If you want the full mechanism and a side-by-side of Ozempic, Wegovy, Mounjaro, and Zepbound, we cover it in GLP-1 Medications Explained. Two things worth flagging here: GLP-1 drugs can cause meaningful muscle loss alongside fat loss, which we unpack in GLP-1 and Muscle Loss, and the gastrointestinal side effects are common enough to matter, covered in Ozempic Side Effects.

BPC-157 and TB-500: popular online, thin on human data

BPC-157 and TB-500 are marketed heavily for healing tendons, joints, and the gut, but the human evidence is close to nonexistent. Most of what circulates online comes from animal studies, often in rats, which do not reliably predict what happens in people.

The legal picture is the part most sellers gloss over. The FDA currently places BPC-157 in Category 2 of its bulk drug substances review, meaning the agency has flagged significant safety concerns and traditional compounding pharmacies cannot legally compound it for human use. A Pharmacy Compounding Advisory Committee meeting scheduled for July 23 to 24, 2026 (FDA docket FDA-2025-N-6895) will revisit whether BPC-157 should be added to the 503A bulks list, with ulcerative colitis as the proposed indication. Until that resolves, almost everything sold as BPC-157 is labeled “research use only,” a phrase that means it was never approved for you to inject.

Growth hormone secretagogues: Ipamorelin, CJC-1295, sermorelin

Growth hormone secretagogues such as ipamorelin, CJC-1295, and sermorelin prompt the body to release its own growth hormone, and they are popular in anti-aging and bodybuilding circles. Sermorelin has a history of medical use for growth hormone deficiency, but the broader anti-aging claims rest on small studies and short follow-up.

The honest summary: raising growth hormone levels is not automatically the same as living longer or building meaningful muscle, and long-term safety in healthy adults has not been established. This is a category where the marketing has run well ahead of the data.

Collagen peptides: where funding bias quietly shapes the headlines

Collagen peptides are the one group on this list you can buy at any grocery store, and the evidence is genuinely mixed in a revealing way. A 2025 systematic review and meta-analysis in The American Journal of Medicine pooled 23 randomized controlled trials with 1,474 participants and found significant improvements in skin hydration, elasticity, and wrinkles.

Here is the detail that rarely makes the supplement ad. In that same analysis, the benefit largely disappeared in the higher-quality trials and in trials that were not funded by industry. Studies backed by supplement or pharmaceutical companies showed an effect; independent, high-quality studies generally did not. Collagen peptides are safe and may help some people, but the size of the benefit has almost certainly been oversold.

How strong is the evidence behind peptides overall?

The evidence behind peptides ranges from rock-solid to almost nonexistent, and lumping them together is the single biggest mistake people make. GLP-1 drugs sit at one end with large, repeated, peer-reviewed trials. BPC-157 and most “recovery” peptides sit at the other, supported mainly by animal data and testimonials.

A useful filter: ask whether a peptide is FDA-approved for a specific condition, and whether there are randomized controlled trials in humans, not just mice. If the answer to both is no, you are in experimental territory, regardless of how confident the seller sounds. To understand how doctors actually measure whether something is helping your body, see Biomarkers Explained.

Are peptides legal, and what is changing in 2026?

Whether a peptide is legal depends entirely on which peptide and how it is sold. FDA-approved peptide drugs like semaglutide are legal with a prescription. Many other peptides exist in a gray zone created by compounding rules, and that zone is narrowing.

In January 2025 the FDA simplified its bulk drug substances framework, and several peptides used in compounding, including BPC-157, were left on the restricted side. The upcoming 2026 advisory committee reviews could either open a legal path for a few of these or shut the door further. The practical takeaway for now: a product being available to buy is not the same as it being legal or approved for human use.

What are the safety risks of peptides?

The biggest safety risks with peptides come less from the molecules themselves and more from where unregulated products are made. Peptides sold as “research chemicals” are not held to pharmaceutical purity standards, so contamination, incorrect dosing, and mislabeling are common and documented concerns.

Even legitimate, approved peptides carry real side effects. GLP-1 drugs commonly cause nausea, vomiting, and diarrhea, and can lead to muscle loss if protein intake and resistance training are neglected. Injecting any peptide also carries infection risk if technique or sourcing is poor. None of this is a reason to panic, but it is a reason to treat peptides as medicine, not as supplements.

Who should and should not consider peptides?

Peptides approved for a diagnosed condition, prescribed and monitored by a clinician, are a reasonable option for the people they were studied in, such as adults with type 2 diabetes or obesity using GLP-1 drugs. For everyone else, the calculus changes fast.

People who should be especially cautious or avoid non-approved peptides include anyone who is pregnant or breastfeeding, anyone with a history of certain cancers, and anyone tempted by injectable “research use only” products bought online. If a peptide is not approved for your situation and you cannot name a human trial supporting it, the safest move is to wait for better evidence.

Frequently asked questions about peptides

Are peptides the same as steroids?

No. Peptides are short amino acid chains that signal cells, while anabolic steroids are synthetic versions of testosterone. Some peptides influence growth hormone, but they work through a different mechanism than steroids and are regulated differently.

Can you take peptides as a pill instead of an injection?

Usually no, because stomach acid and digestive enzymes break most peptides down before they reach the bloodstream. A few drugs, like oral semaglutide, are formulated to survive digestion, but most peptides remain injectable for that reason.

Is BPC-157 legal to buy in the United States?

BPC-157 is not FDA-approved, and the FDA has placed it in Category 2 of its bulk drug substances review, citing safety concerns. Products sold online are typically labeled “research use only,” which means they are not approved for human use. A 2026 FDA advisory meeting may revisit this status.

Do collagen peptides actually work for skin?

The evidence is mixed. Pooled trials show improvements in skin hydration and elasticity, but the benefit shrinks in independent, higher-quality studies and grows in industry-funded ones. Collagen peptides are safe, but the effect is likely smaller than the marketing suggests.

Are GLP-1 drugs considered peptides?

Yes. Semaglutide and tirzepatide are peptide-based drugs that mimic the natural hormone GLP-1. They are the most rigorously studied and clearly effective peptides currently in wide use.

The bottom line on peptides

Peptides are not one thing, and that is the whole point. A short amino acid chain can be a life-changing, well-tested medicine or an untested research chemical sold past the edge of the law. The deciding questions are always the same: Is it FDA-approved for a specific use? Are there human trials, not just animal data? Is it prescribed and monitored by a clinician? When the answers are yes, peptides can be powerful. When they are no, the confident marketing is doing the heavy lifting that the evidence cannot.

Related deep dives

Sources

  • Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). New England Journal of Medicine, 2025.
  • U.S. Food and Drug Administration. Bulk Drug Substances Used in Compounding Under Section 503A; BPC-157 docket FDA-2025-N-6895; Pharmacy Compounding Advisory Committee meeting, July 23 to 24, 2026.
  • Systematic Review and Meta-Analysis of collagen supplementation and skin aging (23 RCTs, 1,474 participants). The American Journal of Medicine, 2025.

This article is for general information and is not medical advice. Talk to a licensed clinician before starting any peptide or medication. See our Medical Disclaimer.